StockData
Myriad Genetics Inc logo

Myriad Genetics Inc (MYGN) stock

MYGNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3070% below fair value
$5.54−0.03 (-0.54%)

Close on Nov 17, 2026Market cap $529.90MP/E –Yield –

Myriad Genetics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Myriad Genetics's profit margin for the twelve months ending Jun 30, 2026 was -14.0%. For fiscal 2025 it was -44.4%, against -15.2% the year before. The highest annual figure on record is 42.0% in fiscal 2010.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-44.4%−29.2
FY2024Dec 31, 2024-15.2%+19.8
FY2023Dec 31, 2023-35.0%−18.4
FY2022Dec 31, 2022-16.5%+14.7
FY2020Jun 30, 2020-31.2%−31.8
FY2019Jun 30, 20190.5%−17.4
FY2018Jun 30, 201817.9%+15.5
FY2017Jun 30, 20172.4%−13.4
FY2016Jun 30, 201615.8%+4.8
FY2015Jun 30, 201511.0%−11.6
FY2014Jun 30, 201422.6%−1.4
FY2013Jun 30, 201324.0%+1.4
FY2012Jun 30, 201222.6%−2.4
FY2011Jun 30, 201125.0%−17.0
FY2010Jun 30, 201042.0%+16.1
FY2009Jun 30, 200925.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ2 2026Jun 30, 2026-22.7%+132.4
Q1 FY2026CQ1 2026Mar 31, 2026-17.0%−17.0
Q4 FY2025CQ4 2025Dec 31, 2025-3.8%+16.4
Q3 FY2025CQ3 2025Sep 30, 2025-13.3%−3.0
Q2 FY2025CQ2 2025Jun 30, 2025-155.1%−137.7
Q1 FY2025CQ1 2025Mar 31, 2025-0.1%+12.8
Q4 FY2024CQ4 2024Dec 31, 2024-20.2%−4.3
Q3 FY2024CQ3 2024Sep 30, 2024-10.4%+21.6
Q2 FY2024CQ2 2024Jun 30, 2024-17.4%+45.9
Q1 FY2024CQ1 2024Mar 31, 2024-12.9%+17.3
Q4 FY2023CQ4 2023Dec 31, 2023-15.9%+7.9
Q3 FY2023CQ3 2023Sep 30, 2023-31.9%−9.5
Q2 FY2023CQ2 2023Jun 30, 2023-63.3%−55.4
Q1 FY2023CQ1 2023Mar 31, 2023-30.2%−17.8
Q4 FY2022CQ4 2022Dec 31, 2022-23.8%+35.7
Q3 FY2022CQ3 2022Sep 30, 2022-22.4%+47.8
Q2 FY2022CQ2 2022Jun 30, 2022-7.9%−3.6
Q1 FY2022CQ1 2022Mar 31, 2022-12.4%−1.4
Q4 FY2020CQ2 2020Jun 30, 2020-59.4%−57.5
Q3 FY2020CQ1 2020Mar 31, 2020-70.2%−73.4
Q2 FY2020CQ4 2019Dec 31, 2019-4.3%−5.5
Q1 FY2020CQ3 2019Sep 30, 2019-11.1%−10.7
Q4 FY2019CQ2 2019Jun 30, 2019-1.9%−9.4
Q3 FY2019CQ1 2019Mar 31, 20193.2%−1.8
Q2 FY2019CQ4 2018Dec 31, 20181.2%−15.2
Q1 FY2019CQ3 2018Sep 30, 2018-0.3%−44.4
Q4 FY2018CQ2 2018Jun 30, 20187.5%+1.3
Q3 FY2018CQ1 2018Mar 31, 20185.0%+3.5
Q2 FY2018CQ4 2017Dec 31, 201716.4%+13.3
Q1 FY2018CQ3 2017Sep 30, 201744.1%+44.5
Q4 FY2017CQ2 2017Jun 30, 20176.2%−2.6
Q3 FY2017CQ1 2017Mar 31, 20171.4%−16.7
Q2 FY2017CQ4 2016Dec 31, 20163.1%−16.1
Q1 FY2017CQ3 2016Sep 30, 2016-0.4%−16.9
Q4 FY2016CQ2 2016Jun 30, 20168.8%−0.9
Q3 FY2016CQ1 2016Mar 31, 201618.1%+6.2
Q2 FY2016CQ4 2015Dec 31, 201519.2%–
Q1 FY2016CQ3 2015Sep 30, 201516.5%–
Q4 FY2015CQ2 2015Jun 30, 20159.7%–
Q3 FY2015CQ1 2015Mar 31, 201511.9%–

More Myriad Genetics figures

See a number that looks wrong?